← All posts

The Price-Transparency Paradox: What 1.7 Million Data Points Reveal

We analyzed 1.7 million prices from 4,469 hospitals. The pattern that emerged reveals a surprising relationship between compliance and cost.

The Compliance-Price Connection

In January 2021, federal law required all US hospitals to publish their prices online. Two years later, we examined how well they complied, and what that compliance revealed about their pricing.

The data came from 4,469 hospitals across all 50 states. Each hospital received a compliance score from 1 to 5, reflecting how transparent they were with their pricing information.

Then we looked at the prices themselves.

The correlation was stark: hospitals with lower compliance scores charged significantly higher prices. Hospitals scoring a 2 on compliance averaged $6,376 per procedure. Those with perfect compliance (score of 5) averaged $1,604.

That’s nearly four times as much.

What This Pattern Means

The relationship is strong and negative: as compliance goes up, prices go down. The statistical relationship is significant and negative.

But why?

There are two plausible explanations. First, hospitals with lower prices may find it easier, even advantageous, to be transparent. If you’re charging competitive rates, you want patients to know.

Second, research shows that more expensive services are less likely to be disclosed. This disparity suggests strategic decision-making by hospital administrators about what to reveal and when.

Either way, the pattern is clear: the hospitals charging the most are the least transparent about it.

The Geography of Price Variation

Location creates dramatic price differences that have nothing to do with quality.

Maryland has the lowest average healthcare prices in our dataset: $619 per procedure. South Dakota has the highest at $6,845. That’s an 11-fold difference for the same medical services.

Even within regions, variation is extreme. A colonoscopy might cost $545 at one facility and $2,200 at another just miles away.

These geographic price variations persist because patients typically don’t know they exist. Transparency threatens to expose pricing that regional monopolies have maintained for years.

Quality vs. Price: A Weak Link

Common wisdom says you get what you pay for. In healthcare, the data tells a different story.

We examined the relationship between hospital quality ratings and prices. Yes, five-star hospitals charge more than one-star hospitals, but only slightly.

Average procedure at a one-star hospital: $1,387. Average at a five-star hospital: $1,827. A 32% premium for significantly better care.

Compare this to the nearly fourfold difference between high-compliance and low-compliance hospitals.

The price-quality relationship is weak. The price-compliance relationship is strong. That suggests pricing is driven more by market opacity than by value delivered.

The Two-Price System

Perhaps the most striking finding: hospitals operate two completely different pricing systems.

Across our dataset, the average list price, what hospitals bill insurance companies, is $3,400. The average cash price, what they charge patients paying directly, is $1,722.

About half.

An EKG has a list price of $190 but a cash price of $124. A complex procedure like removing an ectopic pregnancy? List price: $44,838. Cash price: $25,519.

This dual pricing system makes economic sense for hospitals. They know uninsured patients can’t pay inflated rates, so they discount. But it reveals how arbitrary the list prices actually are.

The challenge? Most patients never see these cash prices. They’re buried in compliance filings that few people access or understand.

Strategic Decisions, Not Just Compliance Costs

Hospital administrators often frame resistance to transparency as an administrative burden. The data suggests something different.

Hospitals already track these prices internally. They already negotiate them with dozens of insurance companies. Publishing them isn’t technically difficult.

What’s difficult is exposing pricing that can’t be easily justified when compared side-by-side with competitors.

Our research suggests compliance is influenced by strategic decisions about what information to disclose, when to disclose it, and how to present it.

The hospitals with the most to lose from comparison are the slowest to comply.

What This Means for Healthcare Strategy

If you’re investing in or managing healthcare organizations, this data reveals a market in transition.

Transparency is increasing, slowly but inevitably. The hospitals that have relied on price opacity to maintain margins face growing pressure.

Three strategic implications emerge:

First, competitive advantage is shifting toward hospitals that can justify their prices through demonstrable quality. The price-quality correlation in the data is weak, which means there’s room for differentiation.

Second, geographic pricing variations will compress as patients gain access to comparison tools. Hospitals in high-price regions need strategies beyond local monopoly.

Third, the dual pricing system (list vs. cash) will face increasing scrutiny. Patients are starting to ask why they should pay insurance rates when cash prices are half as much.

The Research Question That Matters

Price transparency legislation hasn’t failed. It’s working exactly as designed: forcing information into the open.

The question isn’t whether transparency will continue. It will.

The question is: how will hospitals respond strategically as their pricing becomes increasingly visible and comparable?

Our data shows a strong negative correlation between compliance and prices. As more hospitals move toward full compliance, we’ll discover whether transparency actually drives prices down, or whether hospitals find new ways to maintain pricing power.

Either way, the relationship we’ve uncovered between compliance and pricing suggests the transition will be significant. And uneven.

Want to understand how price transparency is reshaping competitive dynamics in healthcare markets? I analyze healthcare pricing data and consumer behavior to identify strategic opportunities and market shifts. Contact me to discuss how these trends affect your investment strategy or business positioning.

Based on analysis of 1.7 million price observations from 4,469 hospitals, published in the Journal of Consumer Affairs.

Kelli

Kelli Frias is a Provost Associate Professor of Marketing at American University’s Kogod School of Business and Principal Investigator of the HealthCARE Lab. She studies how people make decisions in markets that were never designed for them.

The newsletter · Monthly

Invisible Decisions

One decision, explained. A monthly note on how people really decide in healthcare and markets, and what organizations should do about it.